ADMA Biologics Inc
NASDAQ:ADMA
ADMA Biologics Inc
NASDAQ:ADMA
Price:
6.55 USD
1.71%
Market Closed
Updated:
Apr 29, 2024
ADMA Biologics Inc
Cash from Investing Activities
|
ADMA Biologics Inc
Cash from Investing Activities Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Cash from Investing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Investing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
ADMA Biologics Inc
NASDAQ:ADMA
|
Cash from Investing Activities
-$5m
|
CAGR 3-Years
27%
|
CAGR 5-Years
-19%
|
CAGR 10-Years
-5%
|
|
|
Abbvie Inc
NYSE:ABBV
|
Cash from Investing Activities
-$2B
|
CAGR 3-Years
62%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
N/A
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Cash from Investing Activities
-$2.3B
|
CAGR 3-Years
46%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-24%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Cash from Investing Activities
-$26.2B
|
CAGR 3-Years
-69%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-12%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Cash from Investing Activities
-$3.1B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-73%
|
CAGR 10-Years
-50%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Cash from Investing Activities
-$3.2B
|
CAGR 3-Years
-256%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-25%
|
See Also
What is ADMA Biologics Inc's Cash from Investing Activities?
Cash from Investing Activities
-5m
USD
-5m
USD
Based on the financial report for Dec 31, 2023, ADMA Biologics Inc's Cash from Investing Activities amounts to -5m USD.
What is ADMA Biologics Inc's Cash from Investing Activities growth rate?
Cash from Investing Activities CAGR 10Y
-5%
-5%
Over the last year, the Cash from Investing Activities growth was 64%. The average annual Cash from Investing Activities growth rates for ADMA Biologics Inc have been 27% over the past three years , -19% over the past five years , and -5% over the past ten years .
You don't have any saved screeners yet
